Rhenovia Pharma rhenovia.com


Public list: Pharma Startups (4743) Neuroscience Startups (947)

Rhenovia Pharma is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is a provider in the application of biosimulation in the prevention and treatment of neurological, neurodegenerative and psychiatric disorders and diseases.

Rhenovia Pharma is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is a provider in t...Show all

Company (Alive / Active)

Phone: +33 3 89 32 11 80

Fax: (+3) 338-932-7631

Technopole - Mer Rouge Plaza
20C rue de Chemnitz
Mulhouse, 68200
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rhenovia Pharma $1.3M Feb 12, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rhenovia Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Alsace Business AngelsAngel Investor (Group)FranceSeries B, Series A
SODIVaCorporationFrench PolynesiaSeries B, Series A
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Transdermal device for the controlled administration of at least one active ingredient to a patient Jan 30, 2013 Oct 10, 2017 Patent